GLOW Blend 70mg (GHK-Cu / TB-500 / BPC-157)

GLOW 70 is a pre-formulated lyophilized peptide blend for research: GHK-Cu 50mg, TB-500 10mg and BPC-157 10mg in a single 70mg vial.

GLOW Blend 70mg (GHK-Cu / TB-500 / BPC-157) is supplied by Bench Grade Peptides as a lyophilized powder in a sealed, lot-numbered vial, for laboratory research use only — not for human or veterinary use.

Its published Certificate of Analysis (lot 00011, analyzed August 7, 2026) is from Bioviridian, a third-party laboratory, and reports 99.71% purity by HPLC; every published lot is listed on the product's COA page. Vials ship at ambient temperature in protective packaging from Florida (Bench Grade Peptides LLC is registered in Dover, Delaware), with storage notes on the lot's certificate.

GLOW 70 is a pre-formulated lyophilized peptide blend for research: GHK-Cu 50mg, TB-500 10mg and BPC-157 10mg in a single 70mg vial.

The primary literature on this compound includes Blend names are not standardised across suppliers — the compound list and mass split are what define this vial, not the name. Per constituent: Pickart & Margolina, Biomed Res Int (2018) — GHK-Cu. Goldstein et al., Ann NY Acad Sci (2012) — TB-500. Sikiric et al., J Physiol Pharmacol (2014) — BPC-157. No controlled study has examined these three compounds administered together; a blend carries each component's uncertainty plus untested interaction. The references below link directly to the published record.

Lots are synthesized in the USA and verified by HPLC; where a lot's Certificate of Analysis is published, it is in the COA library. It is supplied strictly for laboratory research use.

Research use only. Everything on this page describes laboratory research. This compound is supplied strictly for in-vitro research use; it has not been evaluated or approved by the FDA and is not for human or veterinary use, and nothing here is a protocol or a recommendation.

GLOW Blend 70mg (GHK-Cu / TB-500 / BPC-157)

Further reading in the lab library

Researchers also ordered